Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Berg

Showing results (471-480 of 633) with videos related to

Pageof 64
Sort By:
Journal of Hepatology|June 20, 2014
A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver diseaseHans Dieter Nischalke, Philipp Lutz, Benjamin Krämer, et al.
AIDS (London, England)|September 22, 2006
Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfectionGuenther Schmutz, Mark Nelson, Thomas Lutz, et al.
Alimentary Pharmacology & Therapeutics|November 22, 2020
Hepatitis B virus RNA decline without concomitant viral antigen decrease is associated with a low probability of sustained response and hepatitis B surface antigen lossSylvia M Brakenhoff, Robert A de Man, André Boonstra, et al.
Hepatology (Baltimore, Md.)|March 31, 2015
Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patientsMarta Milano, Alessio Aghemo, Rosellina Margherita Mancina, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 19, 2009
Low-density lipoprotein receptor variants are associated with spontaneous and treatment-induced recovery from hepatitis C virus infectionAndreas Mas Marques, Tobias Mueller, Justus Welke, et al.
Science (New York, N.Y.)|November 29, 2005
Assistance of microbial glycolipid antigen processing by CD1eHenri de la Salle, Sabrina Mariotti, Catherine Angenieux, et al.
Bioinformatics (Oxford, England)|September 8, 2005
Computational methods for the design of effective therapies against drug resistant HIV strainsNiko Beerenwinkel, Tobias Sing, Thomas Lengauer, et al.
Journal of Hepatology|December 15, 2010
Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infectionMichael P Manns, Marc Bourlière, Yves Benhamou, et al.
Gut|April 12, 2012
Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosisRoeland Zoutendijk, Jurrien G P Reijnders, Fabien Zoulim, et al.
Cancers|September 10, 2021
The Prognostic Effect of <i>KRAS</i> Mutations in Non-Small Cell Lung Carcinoma Revisited: A Norwegian Multicentre StudySissel Gyrid Freim Wahl, Hong Yan Dai, Elisabeth Fritzke Emdal, et al.
Pageof 64

Showing results (471-480 of 633) with videos related to

Sort By:
Pageof 64
Journal of Hepatology|June 20, 2014
A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver diseaseHans Dieter Nischalke, Philipp Lutz, Benjamin Krämer, et al.
AIDS (London, England)|September 22, 2006
Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfectionGuenther Schmutz, Mark Nelson, Thomas Lutz, et al.
Alimentary Pharmacology & Therapeutics|November 22, 2020
Hepatitis B virus RNA decline without concomitant viral antigen decrease is associated with a low probability of sustained response and hepatitis B surface antigen lossSylvia M Brakenhoff, Robert A de Man, André Boonstra, et al.
Hepatology (Baltimore, Md.)|March 31, 2015
Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patientsMarta Milano, Alessio Aghemo, Rosellina Margherita Mancina, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 19, 2009
Low-density lipoprotein receptor variants are associated with spontaneous and treatment-induced recovery from hepatitis C virus infectionAndreas Mas Marques, Tobias Mueller, Justus Welke, et al.
Science (New York, N.Y.)|November 29, 2005
Assistance of microbial glycolipid antigen processing by CD1eHenri de la Salle, Sabrina Mariotti, Catherine Angenieux, et al.
Bioinformatics (Oxford, England)|September 8, 2005
Computational methods for the design of effective therapies against drug resistant HIV strainsNiko Beerenwinkel, Tobias Sing, Thomas Lengauer, et al.
Journal of Hepatology|December 15, 2010
Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infectionMichael P Manns, Marc Bourlière, Yves Benhamou, et al.
Gut|April 12, 2012
Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosisRoeland Zoutendijk, Jurrien G P Reijnders, Fabien Zoulim, et al.
Cancers|September 10, 2021
The Prognostic Effect of <i>KRAS</i> Mutations in Non-Small Cell Lung Carcinoma Revisited: A Norwegian Multicentre StudySissel Gyrid Freim Wahl, Hong Yan Dai, Elisabeth Fritzke Emdal, et al.
Pageof 64